Plans to build a long-promised biological manufacturing facility in Manhattan have fizzled, though company leaders prefer not ...

Partnership highlights Scorpius’ expertise in supporting innovative therapeutic programsDURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) ...

Aims to accelerate the lead candidate’s journey toward clinical success and expand its reach to patients who need it.

DURHAM, N.C., Jan. 16, 2025 (GLOBE NEWSWIRE) -- (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today announced that ...

Scorpius announced its collaboration with KaloCyte. Under this initial project, Scorpius will utilize its scientific and technical expertise to ...

Scorpius Holdings (SCPX) announced that the company’s planned 1-for-20 reverse stock split of its common stock that was announced yesterday, ...

Scorpius Holdings, Inc. has announced a collaboration with KaloCyte to improve the manufacturing efficiency of KaloCyte's lead product, ErythroMer™, a bio-engineered artificial red blood cell ...

ThunderCats: Lost #2 introduces Scorpius, a formidable new foe for the ThunderCats. Bengali, Pumyra, and Lynx-O make a return ...

Scorpius Holdings said it will sell 29.4 million shares of its common stock for 34 cents apiece, as it reiterated its going-concern warning. The contract development and manufacturing company said ...

This is the only reason that Farscape did so well with Harvey, a version of the villainous Scorpius that exists only in the head of Crichton, a gimmick character that became a fan favorite despite ...